Home
Scholarly Works
Corrigendum: Progression-Free Survival in Advanced...
Journal article

Corrigendum: Progression-Free Survival in Advanced Ovarian Cancer: A Canadian Review and Expert Panel Perspective

Abstract

AMO has participated on advisory boards for AstraZeneca, Celgene Corporation, and Sanofi–Aventis. [...]

Authors

Oza AM; Castonguay V; Tsoref D; Diaz–Padilla I; Karakasis K; Mackay H; Welch S; Weberpals J; Hoskins P; Plante M

Journal

Current Oncology, Vol. 18, No. 6, pp. 303–303

Publisher

MDPI

Publication Date

December 1, 2011

DOI

10.3390/curroncol18060003

ISSN

1198-0052

Contact the Experts team